Small-Cap Healthcare Stocks Compared on Volatility and Valuation
2 reports, 2 independent
Updated Sat 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Reports compared the volatility and financial metrics of small-cap healthcare companies. Dyadic International has a beta of 0.96, suggesting its share price is 4% less volatile than the S&P 500. Celularity, Inc. has a beta of 0.79, indicating its share price is 21% less volatile than the S&P 500.
Why it matters
Dyadic International is trading at a lower price-to-earnings ratio than both Celularity, Inc. and Arvinas, indicating it is currently more affordable. Dyadic International also reports higher earnings than both Celularity, Inc. and Arvinas, despite having lower revenue than both.